Institute of Cardiovascular Sciences
Widely regarded as one of the preeminent basic cardiovascular research programs in the world, St. Boniface Hospital Research’s Institute of Cardiovascular Sciences, led by Dr. Lorrie Kirshenbaum, is a leading force in the fight against heart disease at the cellular and molecular levels.
Inaugural Berdie & Irvin Cohen (BERVIN) Scholarship granted to Chattopadhyaya
Congratulations to PhD student Sikta Chattopadhyaya Institute of Cardiovascular Sciences, who is the first recipient of a new scholarship created specifically to support doctoral students in their first and second years of study here at the Albrechtsen Research...
Naranjan S. Dhalla Awarded Honorary Doctorate from the University of Banja Luka
At a colourful ceremony on November 7, 2022, attended by more than 300 dignitaries including the Prime Minister of the Republic of Srpska and several Federal Ministers, the University of Banja Luka in Bosnia-Herzegovina bestowed Honorary Doctorate upon Naranjan S....
Research Without Borders Visionary Remembered
Our sincere condolences to BGU Canada on the sudden passing of CEO, Mark S. Mendelson. Mark was a passionate leader and a devoted advocate of Ben-Gurion University of the Negev (BGU) and one of the founding champions of Research Without Borders, a one-of-a-kind...
Advances in Cardiovascular Science and Medicine Through Diversity, Equity, and Inclusion supported by Education, Research, and Technology Innovation
41st North American Section ofThe International Society forHeart Research 9th North American Section ofThe International Academy ofCardiovascular Sciences This cardiovascular conference was the first joint meeting between the North American Section of the...
Young Investigators Net Two Major AHA Awards
With stiff competition from prestigious international universities and research centres, two St. Boniface Hospital Research members each won a major award at the American Heart Association’s 2022 Scientific Sessions, held earlier this month in Chicago. Dr. Inna...
SBRC researchers identify protein linked to heart failure in chemo patients, with potential to save millions of lives.
A team led by Dr. Lorrie Kirshenbaum has identified a protein called TRAF2 that stops functioning in cancer patients taking the chemotherapy drug doxorubicin, which can result in heart failure. Their findings were published in the American Heart Association’s cardiac...